| Literature DB >> 34178776 |
Siamak Heidarzadeh1,2, Mohammad Reza Pourmand1, Saeedeh Hasanvand3, Reyhaneh Pirjani4, Davoud Afshar2, Matina Noori4, Mohammad Mehdi Soltan Dallal1,5.
Abstract
BACKGROUND: Listeria monocytogenes show high mortality among pregnant women and newborns. This study aimed to detect L. monocytogenes in pregnant women with a history of abortion and assess the serotypes, antibiotic susceptibility patterns, and its resistance genes.Entities:
Keywords: Genes; Listeria monocytogenes; Pregnant women
Year: 2021 PMID: 34178776 PMCID: PMC8213617 DOI: 10.18502/ijph.v50i1.5084
Source DB: PubMed Journal: Iran J Public Health ISSN: 2251-6085 Impact factor: 1.429
Identities and nucleotide sequences of L. monocytogenes resistance gene primers
| PCR1 | 5′-AGAGTAATCGGCAAGGATAACG-3′ | 199 bp | [6] | ||
| 5′-AATGGGCAATTTCACAATCC-3′ | |||||
| PCR2 | 5′-GAAAAGGTACTCAACCAAATA-3′ | 636 bp | [6] | ||
| 5′ AGTAACGGTACTTAAATTGTTTAC-3′ | |||||
| PCR3 | 5′-GTGGACAAAGGTACAACGAG-3′ | 405 bp | [6] | ||
| 5′-CGGTAAAGTTCGTCACACAC-3′ |
F: Forward
R: Reverse bp: base pair(s)
Antimicrobial resistance profiles of L. monocytogenes isolated from clinical samples in Iran
| R | I | S | ||||
|---|---|---|---|---|---|---|
| Ampicillin | 10 μg | 0 | 10 (45.45%) | 12 (54.55%) | ||
| Gentamicin | 10 μg | 8 (36.36%) | 0 | 14 (63.64%) | ||
| Penicillin G | 10 U | 0 | 10 (45.45%) | 12 (54.55%) | ||
| Trimethoprim | 5 μg | 11 (50%) | 7 (31.81%) | 4 (18.18%) | ||
| Tetracycline | 30 μg | 10 (45.45%) | 0 | 12 (54.55%) | ||
| Ciprofloxacin | 5 μg | 4 (18.18%) | 0 | 18 (81.82%) | ||
| Sulfamethoxazole | 25 μg | 11 (50%) | 7 (31.82%) | 4 (18.18%) | ||
| Erythromycin | 15 μg | 6 (27.27%) | 4 (18.18%) | 12 (54.55%) | ||
| Streptomycin | 10 μg | 6 (27.27%) | 4 (18.18%) | 12 (54.55%) | ||
| Chloramphenicol | 30 μg | 6 (27.27%) | 6 (27.27%) | 10 (45.45%) | ||
R: resistant, I: intermediate, S: susceptible.
Detection of L. monocytogenes isolates and resistance profiles used in this study
| 4b | |||||
| 1/2b | |||||
| 4b | |||||
| 4b | |||||
| 4b | |||||
| 3c | |||||
| 4b | |||||
| 4b | |||||
| 1/2a | |||||
| 1/2a | |||||
| 1/2b | |||||
| 4b | |||||
| 1/2a | |||||
| 4b | |||||
| 4b | |||||
| 4b | |||||
| 4b | |||||
| 1/2a | |||||
| 1/2b | |||||
| 1/2a | |||||
| 4b | |||||
| 4b |
Positive/Existence of the gene;
Negative/Absence of the gene
Fig. 1:Polymerase chain reaction (PCR) analyses of ermB gene. Agarose gel electrophoresis of PCR product by using upstream and downstream primers. Amplification of the 636-bp fragment of the ermB gene. Lane 1= DNA ladder 100 bp, Lane 2= positive control (Enterococcus faecalis ATCC® 29212TM), Lane 3= negative control (Staphylococcus aureus subsp. aureus ATCC® 29213TM), Lane 4, 5, 6 and 7= positive results
Fig. 3:Polymerase chain reaction (PCR) analyses of dfrD gene. Agarose gel electrophoresis of PCR product by using upstream and downstream primers. Amplification of the 199-bp fragment of the dfrD gene. Lane 1= DNA ladder 100 bp, Lane 2= positive control (Enterococcus faecalis ATCC® 29212TM), Lane 3= negative control (Staphylococcus aureus subsp. aureus ATCC® 29213TM), Lane 4, 5, and 6= positive results